A previous report indicated that GLRX3 is involved in epithelial-to-mesenchymal transition (EMT) in breast cancer, [84]; therefore, we examined the changes in EMT marker by GLRX3 knockdown in pancreatic cancer cells. This evidence concerns the gene GLRX3 and breast cancer.